Gilead Sciences (GILD) Income towards Parent Company (2009 - 2026)
Gilead Sciences (GILD) posted Income towards Parent Company of -$10.5 billion for Q2 2026, compared with $1.96 billion a year earlier.
Gilead Sciences (GILD) Income towards Parent Company (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Income towards Parent Company at Gilead Sciences was -$3.24 billion; for FY2025, it was $8.51 billion.
- Annual Income towards Parent Company shows a five-year compound annual growth rate of 133.3% (FY2020 to FY2025).
- In prior years, Gilead Sciences' Income towards Parent Company was $480 million in FY2024 (-91.5%), $5.67 billion in FY2023 (+23.4%), $4.59 billion in FY2022 (-26.2%) and $6.23 billion in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Income towards Parent Company in data going back to Q1 2009.
- On a year-over-year basis, Income towards Parent Company increased in five of the last six quarters, with growth averaging 37.2%.
- The strongest year-over-year quarter for Income towards Parent Company in the past five years was Q3 2021, with growth of 620.0%; the weakest was Q1 2022, with a decline of 98.9%.
- According to Business Quant data, Income towards Parent Company for the three prior quarters was $2.02 billion (Q1 2026), $2.18 billion (Q4 2025) and $3.05 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.50 Bn |
| Mar 31, 2026 | 2.02 Bn |
| Dec 31, 2025 | 2.18 Bn |
| Sep 30, 2025 | 3.05 Bn |
| Jun 30, 2025 | 1.96 Bn |
| Mar 31, 2025 | 1.32 Bn |
| Dec 31, 2024 | 1.78 Bn |
| Sep 30, 2024 | 1.25 Bn |
| Jun 30, 2024 | 1.61 Bn |
| Mar 31, 2024 | -4.17 Bn |
| Dec 31, 2023 | 1.43 Bn |
| Sep 30, 2023 | 2.18 Bn |
| Jun 30, 2023 | 1.05 Bn |
| Mar 31, 2023 | 1.01 Bn |
| Dec 31, 2022 | 1.64 Bn |
| Sep 30, 2022 | 1.79 Bn |
| Jun 30, 2022 | 1.14 Bn |
| Mar 31, 2022 | 19.00 Mn |
| Dec 31, 2021 | 382.00 Mn |
| Sep 30, 2021 | 2.59 Bn |
Gilead Sciences Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=GILD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();